Belatacept: Is there BENEFIT for liver transplantation too?

Abstract

The results of the multicenter belatacept liver transplant trial disappoint with respect to safety and efficacy, and new approaches will be required before this agent plays a role in liver transplant immunosuppression. See article by Klintmalm et al on page 1817. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.